FCMI
GBIO

Foresite Capital Management IV’s Generation Bio GBIO Stock Holding History

Foresite Capital Management IV’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-85,794
Closed -$24.3M – 14
2020
Q4 		$24.3M Hold
85,794
– – 2.64% 9
2020
Q3 		$26.5M Hold
85,794
– – 5.98% 7
2020
Q2 		$18M Buy
+85,794
New +$19.1M 8.78% 6

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

Foresite Capital Management IV's GBIO Position: Q1 2021 in Review

Foresite Capital Management IV sold out of Generation Bio (GBIO) in Q1 2021, closing a stake of 85,794 shares — an estimated $24.3M sold.

Foresite Capital Management IV first reported a position in GBIO in Q2 2020 and held it in 3 quarters. The position peaked at $26.5M in Q3 2020. 88 funds tracked by Wall St. Rank hold GBIO as of Q1 2021.

  • Foresite Capital Management IV reported no remaining Generation Bio position as of Q1 2021 after selling out during the quarter.
  • Foresite Capital Management IV sold 85,794 Generation Bio shares in Q1 2021, an estimated $24.3M.
  • Foresite Capital Management IV first reported a position in Generation Bio in Q2 2020 and held it in 3 quarters.
  • Foresite Capital Management IV's Generation Bio position peaked at $26.5M in Q3 2020.
  • 88 funds tracked by Wall St. Rank held Generation Bio as of Q1 2021.

Based on Foresite Capital Management IV's 13F filing for Q1 2021, filed 17 May 2021.